glp-1 news nov 2025 Weight-Loss Drug Demonstration Begins July 2026 Alarming rise in weight loss

Performance and Sports Medicine Implications This is where I think the conversation often becomes more useful

In a clinical study, users reported their skin appeared firmer, smoother and less crepey

This blog discusses GLP-1 analogues, like semaglutide, Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide, which are groundbreaking medications for managing weight loss and type 2 diabetes

The results of a transcriptomic analysis obtained from a mouse model also revealed that the stimulation of GLP-1 receptor by high doses of exendin-4 upregulates IGF-1R typically in pancreatic islets, thus reinforcing the concept that activating the IGF-1R/IRS-2/Akt pathway mediates the prevention of -cell loss under the control of incretins (40)